|
0
|
|
Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell-Depleting Therapy With COVID-19: A Target Trial Emulation Study.
(academic.oup.com)
|
Calabrese C
…
Wang XF
Clinical Infectious Diseases
2026-02-04
|
#infection
#covid-19
#clinical trial
#antiviral
#immunocompromised
|
|
0
|
|
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.
(journals.asm.org)
|
Leonard VHJ
…
Ganem D
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#influenza
#antiviral
#inhibitor
#protein-protein interaction
|
|
0
|
|
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.
(academic.oup.com)
|
Kim AY
…
Naggie S
Clinical Infectious Diseases
2026-02-04
|
#clinical trial
#treatment
#antiviral
#hepatitis c
|
|
0
|
|
Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic and Viral Characteristics and Response to Dual and Extended Antiviral Therapy.
(academic.oup.com)
|
Little JS
…
Sherman AC
Clinical Infectious Diseases
2026-02-04
|
#infection
#immunity
#sequencing
#antiviral
|